baber/WOPTO huggingface dataset:
Patent AU-747357-B2 (AU)
Title: Method for reading document entries and addresses
Inventor: SCHAFER HARTMUT
IPC: G06V30/40
Filed: 2000-02-01
Granted: 2002-05-16
Abstract: The invention relates to a method for reading document entries and addresses. In this context, automatic reading is effected using the intermediate steps of layout analysis, classification of the segmented regions and interpretation of the results in a reader, and if necessary video coding. According to the invention, during the reading mode, when information has been clearly read automatically, the image data and the associated reading results and intermediate results, and/or, when information has been clearly ascertained using video coding, the image data and the reading results and intermediate results clearly ascertained in a second automatic reading process including the video coding results are stored for a current random sample. This current random sample is used to readapt the automatic reader.
Patent AU-663909-B2 (AU)
Title: Improvements in or relating to organic compounds
Inventor: REVESZ LASZLO
IPC: G01N33/68
Filed: 1993-01-29
Granted: 1995-10-26
Abstract: The invention relates to a process for producing pyridinoline and deoxypyridinoline crosslinks and derivatives thereof of formula (I) <CHEM> in which X, Y, Z, R1, R2, R3, R4,X1 and X2<(-)> have meanings as given in the description and their use in determining connective tissue disorders in humans and animals.
Patent AU-655389-B2 (AU)
Title: Structural assembly
Inventor: BARDO CHARLES J
IPC: F28C1/00
Filed: 1993-02-19
Granted: 1994-12-15
Abstract: The present invention provides a structural assembly (10) that includes at least four vertically extending columns (30) which form corners of the structural assembly. Wall panels (32,34,36) extend between adjacent columns, with at least two wall panels vertically stacked and connected to each other, to form a structural wall assembly between adjacent columns. The ends of each of the wall panels are attached to flanges that extend from each of the columns. A structural column (24) is provided in the center of the structure and braces (74,75) extend from each of the corner columns to the riser. Beams (58,90) also extend from the central riser outwardly to certain of the wall panels, usually connecting to the wall panels at a location equidistant between the columns. A roof structure (112) is provided, the edges of which are received in spaces in certain of the top wall panels. In a cooling tower application of the present invention, a fan assembly (12) is supported on the top of the central column water inlet riser (24) and includes a fan shroud supported by the roof. <IMAGE>
Patent AU-624375-B2 (AU)
Title: Surface treatment agent for polymer fibers
Inventor: SELTMANN HANS-GUNTHER DR
IPC: D06M15/233
Filed: 1989-05-05
Granted: 1992-06-11
Abstract: Aqueous surface treatment compositions for polymer fibres based on a resin formulation were to be improved in respect of the textile processing properties of the fibres treated therewith and the adhesion of the fibres to a matrix. This was possible by combining
 . 1 - 30% by weight of a polar phenolic resin of the resol type
 . 2 - 40% by weight of a resol-crosslinkable copolymer of a free radical polymerisable aromatic hydroxymethyl and/or methylhalogen compound and
 water to 100% by weight, and also
 if desired up to 5% by weight of further adhesion promoters.
Patent AU-672390-B2 (AU)
Title: Benzodiazepin derivatives useful as CCK-receptor antagonists
Inventor: RYDER HAMISH
IPC: A61P43/00
Filed: 1993-02-26
Granted: 1996-10-03
Abstract: PCT No. PCT/GB93/00404 Sec. 371 Date Sep. 14, 1994 Sec. 102(e) Date Sep. 14, 1994 PCT Filed Feb. 26, 1993 PCT Pub. No. WO93/16999 PCT Pub. Date Sep. 2, 1993This invention relates to benzodiazepine derivatives which are useful as drugs exhibiting antagonism at the gastrin and/or CCK-B receptor, and to their production.
Patent AU-687731-B2 (AU)
Title: Method of treatment of HIV-seropositive individuals with dietary whey protein
Inventor: GOLD PHIL
IPC: A23L1/305
Filed: 1993-03-22
Granted: 1998-03-05
Abstract: Undenatured whey protein concentrate is administered to HIV-seropositive individuals to elevate their blood mononuclear cells, glutathione (GSH) level, body weight and sense of well being. In addition T-helper cells concentration and their T-helper cells/T-suppressor cells ratio are slightly elevated.
Patent AU-636315-B2 (AU)
Title: Ostomy coupling
IPC: A61F5/448
Filed: 1989-11-23
Granted: 1993-04-29
Abstract: A three part ostomy coupling has a first part (20) having a flange (27), a central chute (22) and an array of spaced arcuate walls (25); a second part (10) having a peripheral seal (12) for engaging and surrounding the outer wall of the chute (22) and an outwardly projecting rim (14) capable of a snap fit with the spaced arcuate walls (25); and a third part (30) which is rotatable about the arcuate walls (25) in order to effect a positive lock between the rim (14) and the arcuate walls. The third part or locking ring (30) has on its upper surface ridge-like projections (34) which engage the arcuate walls (25) on rotation of the ring (31). These effect a secure locking of the coupling elements (10) and (20).
Patent AU-671660-B2 (AU)
Title: Liquid phase synthesis of peptides and peptide derivatives
Inventor: SIWRUK GARY A
IPC: C07K1/06
Filed: 1993-06-16
Granted: 1996-09-05
Abstract: A liquid phase peptide synthetic method which uses (1) Fmoc as the protecting group for the non-side chain amino functionality, (2) ammonia, a primary or secondary amine to remove the Fmoc protecting group, and (3) substituted carbodiimide as the coupling agent for the C to N synthesis of peptides or peptide derivatives in a proper organic solvent.
Patent AU-642398-B2 (AU)
Title: System for preventing the use of an unauthorized external memory
Inventor: OKADA SATORU
IPC: G06F9/06
Filed: 1990-01-05
Granted: 1993-10-21
Abstract: A hand-held electronic game machine includes a computer (22) accommodated in a case and a liquid crystal display (LCD) panel (14). When an external memory (16) is inserted to a receiving port (68), a first character data being set in advance in the computer (22) is compared with a second character data stored in a predetermined area of the external memory (16). Prior to such comparison, the computer displays the characters represented by the second character data on the LCD panel. If the first and second character data are coincident with each other, the computer (22) can access to the external memory (16).
Patent AU-582794-B2 (AU)
Title: A device for clearing the neck skin of slaughtered poultry
Inventor: LINDHOLST JORGEN
IPC: A22C21/06
Filed: 1985-10-08
Granted: 1989-04-13
Abstract: A rotatable and displaceable mandrel for clearing the neck skin of slaughtered poultry after its intestinal set has been removed comprises an active portion (2) with a foremost, blunt end portion (4) and one or more rows of tongues (6) therebehind which are forwardly directed towards the end portion and in the direction of rotation of the mandrel and whose points do not extend past the largest perimeter of the end portion (4).
Patent AU-657076-B2 (AU)
Title: Gas phase polymerization reactions utilizing soluble unsupported catalysts
Inventor: BRADY ROBERT CONVERSE III
IPC: C08F10/00
Filed: 1993-10-15
Granted: 1995-02-23
Abstract: Gas phase polymerization processes are disclosed which utilize unsupported soluble transition metal coordination catalysts. The catalysts are introduced into the reactor as a solution.
Patent AU-720966-B2 (AU)
Title: Insulin derivatives
Inventor: MARKUSSEN JAN
IPC: A61K38/28
Filed: 1996-03-18
Granted: 2000-06-22
Abstract: Insulin derivatives in which a lipophilic group having from 12 to 40 carbon atoms is attached to the  alpha -amino group of the N-terminal amino acid in the B-chain or to the carboxy group of the C-terminal amino acid in the B-chain have a protracted profile of action.
Patent AU-694623-B2 (AU)
Title: Process for producing a protein
Inventor: AGELAND HANS
IPC: A61P9/00
Filed: 1996-03-01
Granted: 1998-07-23
Abstract: A substantially endotoxin-free ApoA or ApoE is produced by recombinant DNA technique, suitably in E. coli. Medicaments and methods for treatment of atherosclerosis or cardiovascular diseases employ ApoA or ApoE purified by a process comprising contacting a first aqueous solution comprising ApoA or ApoE and endotoxins with a matrix comprising an immobilized compound with an end group comprising two or three nitrogen atoms bonded to a carbon atom for attaching the endotoxins to the matrix, and subsequently treating the matrix comprising the immobilized compound with a second aqueous solution comprising a surfactant for releasing the ApoA or ApoE while the endotoxins remain attached to the matrix. Alternatively, the ApoA or ApoE is purified by a process comprising contacting the first aqueous solution comprising ApoA or ApoE and endotoxins with an anion-exchange matrix for attaching the ApoA and ApoE to the matrix, treating the anion-exchange matrix with a second aqueous solution comprising a compound comprising two or three nitrogen atoms bonded to a carbon atom for releasing the endotoxins while the ApoA or ApoE remains attached to the matrix, and then releasing the ApoA or ApoE from the matrix.
Patent AU-586992-B2 (AU)
Title: Closed cell phenolic foam
Inventor: LUNT JAMES
IPC: C08J9/14
Filed: 1985-11-11
Granted: 1989-08-03
Abstract: @ This invention relates to the manufacture of foam from phenolic resins and to the foam so produced. In order to overcome some the the limitations of the prior art closed cell phenolic foams, we have developed a method of preparing closed cell foams from modified, low cost phenol formaldehyde resoles, which exhibit high closed cell contents, low friability and low thermal conductivity. This specification provides a foam competitive with urethane foams, which have an aged thermal conductivity of about 0.16K. or less, but which will not generate fumes as toxic as those of urethane. There is, provided a method of making a phenolic foam material comprising the steps of1) preparing a base catalysed phenol-formaldehyde resole having a mole ratio of phenol to formaldehyde of between 1:3 and 1:4.5 and containing substantially no free phenol but including residual formaldehyde;2) neutralizing, concentrating and acidifying said resole;3) reacting with co-reactants consisting essentially of urea and resorcinol in an amount such that the molar ratio of combined urea and resorcinol to free formaldehyde in said resole is about 1:1, the ratio of urea to formaldehyde being selected so that in a test starting at ambient temperature a reaction temperature of 70° to 75°C. is reached during foaming within a period of 4 to 8 minutes, the urea being reacted first where urea and resorcinol are separately reacted with the resole;4) (a) combining the product of step 3 with a surfactant in an amount sufficient to be effective as a cell stabilizer and(b) a blowing agent in an amount sufficient to form a foam;5) initiating foam formation by adding to the mixture of step 4 a catalyst comprising an acidic material to reduce the pH of the mixture to below 4;6) curing the mixture of step 5.
Patent AU-650618-B2 (AU)
Title: Laser amplifier
Inventor: WHITLEY TIMOTHY JOHN
IPC: H01S3/06
Filed: 1990-03-08
Granted: 1994-06-30
Abstract: A laser amplifier having an improved pump efficiency for a given pump power comprises a pump source (46) longitudinally coupled at a plurality of coupling points (47, 48, 49) to an optical fibre (41). By thus coupling the pump power into the fibre (41), a fraction of the pump power is applied to the fibre (41) at each of the coupling points (47, 48, 49). A significant improvement in pump efficiency may be achieved in this way.
Patent AU-677796-B2 (AU)
Title: DNA compounds comprising sequences encoding mannuronan C-5-epimerase
Inventor: ERTESVAG HELGA
IPC: C12N/
Filed: 1993-10-08
Granted: 1997-05-08
Abstract: PCT No. PCT/NO93/00151 Sec. 371 Date May 9, 1995 Sec. 102(e) Date May 9, 1995 PCT Filed Oct. 8, 1993 PCT Pub. No. WO94/09124 PCT Pub. Date Apr. 28, 1994DNA compounds encompassing sequences coding for enzymes having mannuronan C-5-epimerase activity are disclosed and a process for the preparation of such enzymes. The genetic sequences and enzymes prepared may be used in the production of alginates having a definite G/M ratio and block structure. Alginates having a definite G/M ratio may also be produced by selective inactivation of the genetic sequences.
Patent AU-676229-B2 (AU)
Title: Stable extended release oral dosage composition
Inventor: KWAN HENRY K
IPC: A61P11/02
Filed: 1993-10-21
Granted: 1997-03-06
Abstract: A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.
Patent AU-757611-B2 (AU)
Title: Optically active pyrrolopyridazine compounds
Inventor: HAGIHARA MASAHIKO
IPC: A61P1/04
Filed: 2000-06-15
Granted: 2003-02-27
Abstract: An optically active pyrrolopyridazine derivative of the formula (I) or a pharmaceutically acceptable salt thereof: <CHEM> (wherein R<1> is alkyl; R<2> and R<3> are each independently alkyl; R<4> is optionally substituted aryl; and A is imino, oxygen or sulfur). ÄUtilityÜ   The pyrrolopyridazine derivatives or pharmaceutically acceptable salts thereof of the present invention exhibit excellent gastric acid secretory inhibition activity and gastric mucous membrane protection activity, as well as excellent antibacterial activity against Helicobacter pylori. They are useful medicines and particularly useful for treating or preventing ulcerative diseases.
Patent AU-681870-B2 (AU)
Title: A method for the manufacturing of an absorbent structure andan absorbent article comprising an absorbent structure manufactured according to this method
Inventor: OSTERDAHL EJE
IPC: A61F13/53
Filed: 1993-11-15
Granted: 1997-09-11
Abstract: A method of producing an absorbent structure in an absorbent article includes the steps of compressing an air laid web of cellulose fibers into a dry-formed sheet having a first density of between 0.2-1.0 g/cm2 and mechanically softening the compressed sheet by a noncutting method to a second density, which is lower than the first density, whereby the sheet is delaminated so as to form a plurality of partially separated thin fiber layers, each of which layers exhibits a density which corresponds to the first density.
Patent AU-601361-B2 (AU)
Title: Hybridisation method and probes therefor
Inventor: CARR FRANCIS JOSEPH
IPC: C12Q1/6816
Filed: 1986-04-11
Granted: 1990-09-13
Abstract: A method for discriminating between two complementary nucleotide sequences differing by as little as 1-3 nucleotides is described in which an oligonucleotide signalling complex probe is used, which probe comprises a single stranded oligonucleotide of 8 to 30 nucleotide units having covalently attached thereto, at a sterically tolerant site, a residue capable of producing a non-radioisotopic signal and having a molecular weight of at least 100 daltons. Oligonucleotide signalling complex probes and diagnostic kits for use in such a method are described and claimed.
Patent AU-769546-B2 (AU)
Title: Method for obtaining transgenic plants expressing a protein with activity producing hydrogen peroxide by transformation by Agrobacterium rhizogenes
Inventor: PAGNIEZ MICHEL
IPC: C12N15/82
Filed: 1999-10-08
Granted: 2004-01-29
Abstract: The subject of the present invention is a method for obtaining transgenic plants expressing a protein with H<SUB>2</SUB>O<SUB>2 </SUB>producing activity, which comprises the following steps of: (a) transforming plant cells with Agrobacterium rhizogenes containing a vector carrying a gene encoding a protein producing H<SUB>2</SUB>O<SUB>2 </SUB>in a context which allows its expression in the plant; (b) selecting the transformants which contain and express this gene, by a peroxidase-based colorimetric test; (c) regenerating the plants from the roots selected and monitoring the expression of the plantlets obtained by a peroxidase-based colorimetric test; (d) sorting according to phenotype and optionally carrying out the molecular analysis of the progeny of the transgenic plants, allowing the selection or the confirmation of transgenic plants obtained containing only the transgene and not the T-DNA specific to A. rhizogenes. Application: Obtaining of transgenic plants
Patent AU-591689-B2 (AU)
Title: Manufacture of wire scribed circuit boards
Inventor: MORINO RONALD
IPC: H05K3/10
Filed: 1986-07-18
Granted: 1989-12-14
Abstract: The invention relates to a process for scribing and bonding insulated wire conductors (14) in a predetermined pattern on a substrate (10), bonding said conductor substantially simultaneously when it contacts the surface of the adhesive (16) by directing substantially uniform laser beam pulses (30) at said adhesive, and timing the pulses such that the pulse repetition rate is a function of the scribing speed.
Patent AU-772558-B2 (AU)
Title: Anti-rolling and anti-pitching system for a motor vehicle, and device for making the same
Inventor: BUJ JOSEP FONTDECABA
IPC: B60G21/04
Filed: 2000-07-27
Granted: 2004-04-29
Abstract: This antiroll and antiheading system for a vehicle, and the device for its implementation that cooperates the vehicle suspension or substituting it, allows that the wheeling sets keep contact with the ground and a uniform load distribution even when the case of an irregular terrain, being such wheeling sets related two-to-two in a diagonal arrangement through interaction means that receive the thrust of one or more wheeling sets and adapt them to transmit them to the other wheeling set, with the purpose of maintaining the uniform load distribution and reduce the roll and heading of the vehicle. The vertical forces detected in the wheeling sets work through mechanic, hydraulic or electric means made up by mechanic resilient elements, hydraulic and/or pneumatic elements and electronic devices.   <IMAGE>
Patent AU-715857-B2 (AU)
Title: Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles
Inventor: GERDES JOHN C
IPC: C12Q1/6834
Filed: 1996-07-12
Granted: 2000-02-10
Abstract: The invention describes an assay for detecting amplified target nucleic acid sequences with a visual signal. The sensitivity and specificity of the methodology are based on bifunctional target labeling during the amplification step or subsequent hybridization that generates a bifunctional label. The invention may be used, for example, in the screening of amplicon detection for the purpose of more efficiently screening libraries. The invention is also useful to detect nucleic acid sequences indicative of a genetic defect or contagious disease when used with the appropriate primers, as well as detect the existence of nucleic acid amplification.
Patent AU-765353-B2 (AU)
Title: A tray container and blank
Inventor: BRAS PHILIPPE LE
IPC: B65D5/22
Filed: 1999-10-14
Granted: 2003-09-18
Abstract: A tray and a blank (10) for forming a tray for holding foodstuff or the like which tray is formed from paperboard or similar foldable sheet material, the tray including the base (14) wherein the base (14) has a doubled skinned zone (82) providing a void (66) wherein means are provided to give fluid communication between the internal surface of the base (14) and said void (66) so that fluid present in the tray can drain into the void (66).
Patent AU-538993-B2 (AU)
Title: Sulphonamido phenyl carboxylic acids
Inventor: WITTE ERNST-CHRISTIAN
IPC: A61K31/185
Filed: 1981-01-05
Granted: 1984-09-06
Abstract: The invention provides sulphonamides of the formula    <IMAGE>  (I) wherein R is a hydrogen atom or a lower alkyl radical; R1 is alkyl, aryl, aralkyl or aralkenyl, the aryl moiety of which in each case can be optionally substituted one or more times by hydroxyl, halogen, trifluoromethyl, lower alkyl or alkoxy or by acyl, carboxy or alkoxycarbonyl; n is 1, 2 or 3; and W is a valence bond or a divalent aliphatic hydrocarbon linkage and the physiologically acceptable salts, esters and amides of such compound. These compounds have excellent pharmacological lipid depressing activity and inhibit thrombocyte aggregation.
Patent AU-718655-B2 (AU)
Title: Heat exchange apparatus and process
Inventor: DUNNE MICHAEL DAVID
IPC: C01B3/38
Filed: 1996-07-29
Granted: 2000-04-20
Abstract: PCT No. PCT/GB96/01812 Sec. 371 Date May 27, 1997 Sec. 102(e) Date May 27, 1997 PCT Filed Jul. 29, 1996 PCT Pub. No. WO97/05947 PCT Pub. Date Feb. 20, 1997Heat exchange apparatus and process, particularly heat exchange primary reforming with the primary reformed gas being subjected to partial combustion (and optionally secondary reforming) and the resultant partially combusted gas being used as the heat exchange medium to supply heat required for the primary reforming. The apparatus includes process fluid inlet and outlet zones separated from the heat exchange zone by boundary means such as tube sheets or header pipes. A plurality of heat exchange tubes for a process fluid extending through a heat exchange zone from one of the boundary means and slideably engage at the other boundary means with seal tubes fastened to said other boundary means. The interior of the inner one of the seal tube and its associated heat exchange tube is provided with a constriction of reduced cross-sectional area forming a low pressure region downstream of said constriction, an expansion region of cross-sectional area greater than that of the constriction downstream of said constriction, and one or more passages through the wall of that inner tube connecting said low pressure region to the exterior of the inner tube. The passages are located within the overlapping region of the seal tube and heat exchange tube so as to provide a leakage flow path for heat exchange medium from the heat exchange zone through the overlapping region and said passages, into the low pressure region.
Patent AU-590032-B2 (AU)
Title: Controlled formation of light and heavy fluff zones
Inventor: ENLOE KENNETH MAYNARD
IPC: D04H1/736
Filed: 1986-12-09
Granted: 1989-10-26
Abstract: The present invention provides an improved apparatus for forming a fibrous web (24), and includes a fibrous supply mechanism (11) for providing fibers (10) of web material. The fibers (10) are deposited onto a foraminous web forming layer (122) which may optionally have a pocket recess (22) formed therein. A foraminous spacing mechanism (120,121) supports the web forming layer (122) while allowing a substantially unrestricted gas flow from a region immediately adjacent to and downstream from the web forming layer (122). A gas flow regulating layer (135) has a selected pattern of apertures therethrough, and is fixedly positioned in adjacent facing relation with the foraminous spacing means (120,121). The regulating layer (135) provides a selected pattern of gas flow through the web forming layer (122). The regulating layer (135), the foraminous spacing mechanism (120,121) and the gas flow regulating layer (135) are constructed to form an installable and replaceable assembly, and a flow forcing mechanism provides a flow of gas through the web forming layer (122).
Patent AU-641210-B2 (AU)
Title: Gastrin releasing peptide receptor
Inventor: FELDMAN RICHARD I
IPC: A61K39/395
Filed: 1990-10-23
Granted: 1993-09-16
Abstract: The gastrin releasing peptide receptor is solubilized and purified in an active form. The amino acid sequence and DNA encoding the receptor are provided.